The American Association for Cancer Research named 15 recipients of its Trailblazer Cancer Research Grants during the opening ceremony of AACR Annual Meeting 2026 in San Diego. Nine early-stage investigators and six mid-career investigators will each receive $1 million over three years to support cancer biology, translational science, and patient-outcome research.
The American Association for Cancer Research on Sunday named the recipients of its Trailblazer Cancer Research Grants during the opening ceremony of the AACR Annual Meeting 2026 in San Diego.
The organization said 15 investigators were selected for the program: nine early-stage investigators and six mid-career investigators. Each recipient will receive $1 million over three years.
AACR said the grants are intended to support research in cancer biology, translational science, and patient-outcome research. The program is funded through Pfizer's donation, according to AACR.
The announcement marks the first public naming of the full group of awardees after the program was introduced ahead of the annual meeting. AACR also highlighted the grants in its live meeting coverage on April 19, confirming that the recipients were announced at the opening ceremony.
The Trailblazer awards are among the more closely watched funding announcements at AACR's annual meeting because they combine substantial multiyear support with a broad mandate across basic, translational, and outcomes research.
Revision note
Initial automated publication.